Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-hexanedione toxicity.
PMID 19936068 · PMC2774515 · PloS one · 2009 · 8 claims · 7 setups
Haplogroup J1 background greatly increases sensitivity of LHON cells (11778/ND4 and 14484/ND6 mutations) to 2,5-HD toxicity
-
Full-text index only
Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells.
PMID 15248896 · PMC481082 · Molecular cancer · 2004 · 8 claims · 8 setups
An unreported T14634C mutation in the mtDNA-encoded ND6 subunit of Complex I is present in the hypoxia-sensitive glioma cell line M010b but not in hypoxia-tolerant lines.
-
Full-text index only
Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression.
PMID 14710226 · PMC2395336 · British journal of cancer · 2004 · 7 claims · 5 setups
There is a surprisingly high correlation between transcription and translation for the subset of genes studied by parallel microarray and proteomics analysis
-
Full-text index only
Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells.
PMID 17705834 · PMC2000881 · BMC neuroscience · 2007 · 6 claims · 5 setups
SILAC-based quantitative proteomics combined with SDS-PAGE and LC-MS/MS can identify and quantify mitochondrial protein abundance changes in dopaminergic MES cells exposed to rotenone vs. control
-
Full-text index only
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
PMID 18577749 · PMC2483574 · Journal of the National Cancer Institute · 2008 · 7 claims · 8 setups
CHD5 promoter is highly methylated in neuroblastoma cell lines with 1p deletion and absent CHD5 expression (NLF, IMR5)